A Multi-Site Hybrid Type I Effectiveness-Implementation Randomized Trial of an Emergency Care Action Plan for Infants With Medical Complexity
Launched by UNIVERSITY OF VERMONT · May 19, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how an Emergency Care Action Plan (ECAP) can help infants with complex medical needs. Infants with medical complexity often need more emergency care than other children, leading to more hospital visits and higher healthcare costs. The goal of the study is to see if this new plan can reduce the number of hospital admissions for these infants and if families and healthcare providers find it helpful and easy to use. The trial will take place at four hospitals across the United States.
To be eligible for this trial, infants need to be between 0 to 6 months old and be admitted to one of the participating hospitals. They must also have multiple significant chronic health problems that require specialized care. It's important that a caregiver agrees to participate in the study and complete follow-up surveys. Families who join the trial can expect to work closely with healthcare providers and will be monitored over a year to see how the ECAP impacts their child's care and health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 0 to 6 months
- • Admitted to the University of Vermont Medical Center, Cincinnati Children's Hospital, Children's Hospital of Philadelphia, or Colorado Children's Hospital Neonatal Intensive Care Unit (NICU),
- • Meets or is expected to meet Children with Medical Complexity status as determined by the treating NICU clinician and defined as "children with multiple significant chronic health problems including multiple organ systems, which result in functional limitations, high health care needs or utilization, and often require need for, or use of, medical technology."
- • Has three or more documented complex chronic conditions (CCCs)
- Exclusion Criteria:
- • Does not have a caregiver participant who agrees to their participation in the study to complete follow-up surveys
- • Does not intend to use the hospital or affiliated sites of which they were recruited from for care during the one-year trial period
About University Of Vermont
The University of Vermont (UVM) is a leading academic institution known for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UVM leverages its diverse expertise in medicine, public health, and biomedical sciences to conduct cutting-edge clinical studies. The university aims to translate scientific findings into effective treatments and interventions, ultimately improving patient outcomes and contributing to the broader medical community. UVM's research facilities and access to a wide patient population support its mission to foster a culture of inquiry and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burlington, Vermont, United States
Cincinnati, Ohio, United States
Aurora, Colorado, United States
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported